Header cover image

U.S. Pharmaceuticals & Biotech Growing Companies With Insider Buying

UPDATED Sep 30, 2022

Insider Buying Ratio of 80%-100%, with forecast growth, and a respectable return on equity.

2 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
LLYEli LillyUS$323.353.8%40.8%US$307.2bUS$337.76PE54xE21.9%1.2%
MEDPMedpace HoldingsUS$157.178.1%-19.7%US$4.9bUS$145.33PE23.3xE9.6%n/a
Page 1 of 1